| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.36 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |